Medicine Spending "Not To Be Viewed In Isolation"

16 October 1994

UK Health Secretary Virginia Bottomley has been told that medicines are one of the most cost effective forms of health care treatment and it is important that the financial benefits they offer are fully understood.

The comments were made to Mrs Bottomley by Chris Tobin, head of Bayer's pharmaceutical business, during a fringe meeting of the Conservative Party Conference in Bournemouth, at which she made the keynote address.

"When medicine costs are considered alongside the cost of other aspects of total patient care," Mr Tobin said, "the benefits of increased medicine expenditure are evident. The cost of a year's therapy on any of the top 10 medicines is less than the cost of two days in hospital."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight